Nextech V Oncology S.c.s., Sicav-sif - Net Worth and Insider Trading

Nextech V Oncology S.c.s., Sicav-sif Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nextech V Oncology S.c.s., Sicav-sif owns 1 companies in total, including PMV Pharmaceuticals Inc (PMVP) .

Click here to see the complete history of Nextech V Oncology S.c.s., Sicav-sif’s form 4 insider trades.

Insider Ownership Summary of Nextech V Oncology S.c.s., Sicav-sif

Ticker	Company	Transaction Date	Type of Owner
PMVP	PMV Pharmaceuticals Inc	2020-09-24	10 percent owner

Nextech V Oncology S.c.s., Sicav-sif Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nextech V Oncology S.c.s., Sicav-sif Ownership Network

Ownership Network List of Nextech V Oncology S.c.s., Sicav-sif

No Data

Ownership Network Relation of Nextech V Oncology S.c.s., Sicav-sif

Nextech V Oncology S.c.s., Sicav-sif Owned Company Details

What does PMV Pharmaceuticals Inc do?

Who are the key executives at PMV Pharmaceuticals Inc?

Nextech V Oncology S.c.s., Sicav-sif is the 10 percent owner of PMV Pharmaceuticals Inc. Other key executives at PMV Pharmaceuticals Inc include SVP & Regulatory Affairs and QA Deepika Jalota , 10 percent owner Orbimed Advisors Llc , and Chief Medical Officer Leila Alland .

PMV Pharmaceuticals Inc (PMVP) Insider Trades Summary

Over the past 18 months, Nextech V Oncology S.c.s., Sicav-sif made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 7,218 shares made by Deepika Jalota , and a net sale of 2,891 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,109 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 10,109 shares.

PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.

PMV Pharmaceuticals Inc Insider Transactions

No Available Data

Nextech V Oncology S.c.s., Sicav-sif Mailing Address

Above is the net worth, insider trading, and ownership report for Nextech V Oncology S.c.s., Sicav-sif. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Nextech V Oncology S.c.s., Sicav-sif's mailing address is: Luxembourg-findel N4 L-1748.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.